Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Apr 30  •  11:14AM ET
0.3880
Dollar change
-0.0117
Percentage change
-2.93
%
Index
-
P/E
-
EPS (ttm)
-8.25
Insider Own
9.53%
Shs Outstand
8.32M
Perf Week
-3.91%
Market Cap
3.23M
Forward P/E
-
EPS next Y
-
Insider Trans
0.00%
Shs Float
7.53M
Perf Month
-26.96%
Enterprise Value
31.60M
PEG
-
EPS next Q
-
Inst Own
1.23%
Perf Quarter
-50.89%
Income
-18.31M
P/S
3.08
EPS this Y
-
Inst Trans
0.92%
Perf Half Y
-81.52%
Sales
1.05M
P/B
-
EPS next Y
-
ROA
-78.94%
Perf YTD
-67.67%
Book/sh
-3.77
P/C
29.39
EPS next 5Y
-
ROE
-214.52%
52W High
4.74 -91.81%
Perf Year
-89.60%
Cash/sh
0.01
P/FCF
-
EPS past 3/5Y
33.45% 25.06%
ROIC
-198.42%
52W Low
0.34 14.42%
Perf 3Y
-98.65%
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
- -
Gross Margin
44.40%
Volatility
9.22% 15.41%
Perf 5Y
-99.75%
Dividend TTM
-
EV/Sales
30.10
EPS Y/Y TTM
75.73%
Oper. Margin
-733.08%
ATR (14)
0.07
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
0.09
Sales Y/Y TTM
-21.23%
Profit Margin
-1743.75%
RSI (14)
37.63
Recom
-
Dividend Gr. 3/5Y
- -
Current Ratio
0.10
EPS Q/Q
78.04%
SMA20
-13.87%
Beta
-0.04
Target Price
-
Payout
-
Debt/Eq
0.10
Sales Q/Q
-100.00%
SMA50
-36.07%
Rel Volume
0.02
Prev Close
0.40
Employees
2
LT Debt/Eq
0.00
Earnings
-
SMA200
-74.13%
Avg Volume
7.23M
Price
0.39
IPO
Dec 06, 2016
Option/Short
No / Yes
EPS/Sales Surpr.
- -
Trades
Volume
38,680
Change
-2.93%
Apr-21-26 08:30AM
Mar-31-26 09:00AM
Mar-02-26 05:23AM
Feb-27-26 05:30PM
08:57AM
09:20PM Loading…
Feb-26-26 09:20PM
03:54PM
10:09AM
08:30AM
08:01AM
Feb-18-26 08:00AM
Feb-02-26 09:00AM
Jan-22-26 09:00AM
Jan-21-26 09:35AM
Jan-20-26 09:00AM
09:00AM Loading…
Jan-12-26 09:00AM
Dec-30-25 09:00AM
Dec-15-25 08:30AM
08:20AM
Dec-01-25 09:00AM
Aug-28-25 09:00AM
Jul-28-25 09:00AM
Jul-14-25 08:00AM
Jun-26-25 08:00AM
Apr-29-25 08:00AM
Apr-15-25 08:00AM
Apr-10-25 08:00AM
Apr-01-25 09:00AM
Mar-10-25 08:00AM
Feb-27-25 08:00AM
09:00AM Loading…
Feb-18-25 09:00AM
Nov-21-24 09:00AM
Nov-18-24 09:00AM
Oct-31-24 09:00AM
Oct-25-24 09:00AM
08:31AM
Oct-24-24 09:00AM
Oct-09-24 09:00AM
Aug-14-24 08:00AM
07:30AM
Jul-31-24 08:00AM
Jul-18-24 09:00AM
Jun-21-24 07:30AM
Jun-20-24 08:30AM
Jun-04-24 11:00AM
08:55AM
07:28AM
Jun-03-24 02:53PM
May-24-24 05:00PM
May-21-24 08:30AM
Apr-22-24 09:00AM
Apr-16-24 09:52AM
Mar-28-24 09:00AM
Dec-18-23 09:00AM
Oct-18-23 09:00AM
Oct-04-23 09:00AM
Sep-13-23 09:15AM
Sep-05-23 08:00AM
Aug-30-23 10:45AM
09:00AM
Aug-21-23 09:00AM
Jul-24-23 09:00AM
Jul-19-23 09:00AM
Jul-10-23 09:00AM
Apr-27-23 09:00AM
Apr-17-23 09:00AM
Apr-11-23 09:00AM
Mar-03-23 09:00AM
Feb-13-23 09:00AM
Jan-17-23 09:00AM
Jan-11-23 09:00AM
Jan-03-23 09:00AM
Dec-14-22 09:00AM
Dec-12-22 09:00AM
Avalon GloboCare Corp. is a clinical-stage biotechnology company, which engages in the development of immune effector cell therapy and laboratory services. It operates through the Real Property Operating and Medical Related Consulting Services segments. The Real Property Operating segment includes property management fees, property insurance, real estate taxes, depreciation, repairs and maintenance fees, utilities and other expenses related to rental properties. The Medical Related Consulting segment relates to labor and related benefits, travel expenses, and related to consulting services. The company was founded on July 28, 2014 and is headquartered in Freehold, NJ.